Community-based, Peer-delivered PrEP for Female Sex Workers in Rural Uganda: The Peers for PrEP (P4P) Study
P4P
2 other identifiers
interventional
140
1 country
1
Brief Summary
The overall goal of the P4P: Peers for PrEP (pre-exposure prophylaxis) study is to pilot test a peer-led and delivered intervention for biomedical HIV prevention that is tailored to women who engage in sex work in southwestern Uganda. This study will evaluate whether this intervention is feasible, acceptable, and increases uptake of biomedical prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedStudy Start
First participant enrolled
April 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedJuly 14, 2025
July 1, 2025
10 months
April 1, 2024
July 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Uptake of biomedical prevention
Number of participants receiving biomedical prevention (e.g., oral pre-exposure prophylaxis \[PrEP\] or post-exposure prophylaxis \[PEP\]) divided by the number of participants
6 months
Secondary Outcomes (2)
Feasibility of delivery of the P4P intervention by peers
6 months
Acceptability of the P4P intervention
6 months
Study Arms (1)
P4P intervention
OTHERPeer-led PrEP/PEP intervention
Interventions
The final Peers for PrEP (P4P) intervention components were refined based on stakeholder engagement, key informant interviews, and focus group discussions. Trained peers will deliver the following intervention with remote clinician support and ongoing mentorship: pre-exposure prophylaxis (PrEP) access and refills in community/at hotspots; HIV testing, with option for HIV self-testing (HIVST); Rapid post-exposure prophylaxis (PEP) access for unplanned exposures; Family planning integration; Phone/text messaging hotline for peer support
Eligibility Criteria
You may qualify if:
- Female sex at birth
- Self-identified as commercial sex worker; exchange of sex for goods or money in last 3 months; or work or live in setting associated with sex work
- Age \>=18 years (or mature minor \>=15 years)
- HIV-negative by country-standard rapid testing algorithm
You may not qualify if:
- Contraindication to country-recommended PrEP regimen per national guidelines
- Unable or unwilling to provide informed consent
- Participation in another HIV prevention study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Gilead Sciencescollaborator
Study Sites (1)
Infectious Diseases Research Collaboration
Kampala, Uganda
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Koss, MD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2024
First Posted
April 9, 2024
Study Start
April 24, 2024
Primary Completion
February 14, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
July 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share